Potential Role for the Use of Gliptins in Cystic Fibrosis-related Diabetes Comment

被引：2
作者：
Ismail, Heba M. [1 ]
机构：
[1] Indiana Univ Sch Med, Dept Pediat, 635 Barnhill Dr,Rm 2053, Indianapolis, IN 46202 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2021年 / 106卷 / 11期
关键词：
cystic fibrosis-related diabetes; abnormal glucose tolerance; DDP-4; inhibitor; sitagliptin; insulin; glucagon; incretin; glucose-dependent insulinotropic polypeptide; glucagon-like peptide1 (GLP-1); GLUCOSE;
D O I：
10.1210/clinem/dgab442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E4786 / E4788
页数：3
相关论文
共 8 条
  • [1] LONGITUDINAL EVALUATION OF GLUCOSE-TOLERANCE AND INSULIN-SECRETION IN NONDIABETIC CHILDREN AND ADOLESCENTS WITH CYSTIC-FIBROSIS - RESULTS OF A 2-YEAR FOLLOW-UP
    ARRIGO, T
    CUCINOTTA, D
    NIBALI, SC
    DICESARE, E
    DIBENEDETTO, A
    MAGAZZU, G
    DELUCA, F
    [J]. ACTA PAEDIATRICA, 1993, 82 (03) : 249 - 253
  • [2] Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes - Preclinical biology and mechanisms of action
    Drucker, Daniel J.
    [J]. DIABETES CARE, 2007, 30 (06) : 1335 - 1343
  • [3] Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial
    Geyer, Myfanwy C.
    Sullivan, Thomas
    Tai, Andrew
    Morton, Judith M.
    Edwards, Suzanne
    Martin, A. James
    Perano, Shiree J.
    Gagliardi, Lucia
    Rayner, Christopher K.
    Horowitz, Michael
    Couper, Jennifer J.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (03) : 700 - 704
  • [4] Kelly A, J CLIN ENDOCR METAB, V2021
  • [5] Gastric Emptying, Incretin Hormone Secretion, and Postprandial Glycemia in Cystic Fibrosis-Effects of Pancreatic Enzyme Supplementation
    Kuo, Paul
    Stevens, Julie E.
    Russo, Antonietta
    Maddox, Anne
    Wishart, Judith M.
    Jones, Karen L.
    Greville, Hugh
    Hetzel, David
    Chapman, Ian
    Horowitz, Michael
    Rayner, Christopher K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (05) : E851 - E855
  • [6] PANCREAS AND GUT HORMONE RESPONSES TO ORAL GLUCOSE AND INTRAVENOUS GLUCAGON IN CYSTIC-FIBROSIS PATIENTS WITH NORMAL, IMPAIRED, AND DIABETIC GLUCOSE-TOLERANCE
    LANNG, S
    THORSTEINSSON, B
    RODER, ME
    ORSKOV, C
    HOLST, JJ
    NERUP, J
    KOCH, C
    [J]. ACTA ENDOCRINOLOGICA, 1993, 128 (03): : 207 - 214
  • [7] Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality
    Moran, Antoinette
    Dunitz, Jordan
    Nathan, Brandon
    Saeed, Asad
    Holme, Bonnie
    Thomas, William
    [J]. DIABETES CARE, 2009, 32 (09) : 1626 - 1631
  • [8] Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
    Sheikh, Saba
    Gudipaty, Lalitha
    De Leon, Diva D.
    Hadjiliadis, Denis
    Kubrak, Christina
    Rosenfeld, Nora K.
    Nyirjesy, Sarah C.
    Peleckis, Amy J.
    Malik, Saloni
    Stefanovski, Darko
    Cuchel, Marina
    Rubenstein, Ronald C.
    Kelly, Andrea
    Rickels, Michael R.
    [J]. DIABETES, 2017, 66 (01) : 134 - 144
1